Pfizer Documents Analysis
Comparisons Between Pfizer’s EUA, Pfizer’s Cumulative Analysis of Post-Authorization Adverse Event Reports, and New Studies Raises Several New Questions
There was a recent study that was published on January 25, 2022 with data compiled from December 2020 through August 2021. https://jamanetwork.com/journals/jama/fullarticle/2788346 There is a cross over in timeline between that new study and Pfizer’s Cumulative Analysis of Post-Authorization Adverse Event Reports, document 5.3.6. https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf Document 5.3.6 contains data from December 2020 …